- Home
- LEGT vs TIL Comparison
LEGT vs TIL Comparison
Compare LEGT & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- TIL
- Stock Information
- Founded
- LEGT 2023
- TIL 2018
- Country
- LEGT United States
- TIL United States
- Employees
- LEGT N/A
- TIL N/A
- Industry
- LEGT
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- LEGT
- TIL Health Care
- Exchange
- LEGT Nasdaq
- TIL Nasdaq
- Market Cap
- LEGT 263.0M
- TIL 218.4M
- IPO Year
- LEGT 2024
- TIL 2021
- Fundamental
- Price
- LEGT $10.26
- TIL $30.84
- Analyst Decision
- LEGT
- TIL Buy
- Analyst Count
- LEGT 0
- TIL 4
- Target Price
- LEGT N/A
- TIL $103.67
- AVG Volume (30 Days)
- LEGT 62.7K
- TIL 137.8K
- Earning Date
- LEGT 01-01-0001
- TIL 11-19-2024
- Dividend Yield
- LEGT N/A
- TIL N/A
- EPS Growth
- LEGT N/A
- TIL N/A
- EPS
- LEGT N/A
- TIL N/A
- Revenue
- LEGT N/A
- TIL N/A
- Revenue This Year
- LEGT N/A
- TIL N/A
- Revenue Next Year
- LEGT N/A
- TIL N/A
- P/E Ratio
- LEGT N/A
- TIL N/A
- Revenue Growth
- LEGT N/A
- TIL N/A
- 52 Week Low
- LEGT $10.00
- TIL $6.08
- 52 Week High
- LEGT $10.47
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- TIL 43.71
- Support Level
- LEGT N/A
- TIL $24.31
- Resistance Level
- LEGT N/A
- TIL $44.50
- Average True Range (ATR)
- LEGT 0.00
- TIL 3.59
- MACD
- LEGT 0.00
- TIL -0.28
- Stochastic Oscillator
- LEGT 0.00
- TIL 32.34
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.